The presence of CXCR4 on endothelial cells in HCC has been observed previously [39, 47], although there was no association with tumor stage or grade, and specific targeting of the CXCL12/CXCR4 axis as an antiangiogenic strategy in HCC was recently suggested [67]. This evidence concerns the gene CXCL12 and hepatocellular carcinoma.